Hypothalamic-pituitary-adrenal axis activity in panic disorder: Effects of alprazolam on 24 h secretion of adrenocorticotropin and cortisol

Journal of Psychiatric Research

Volumn 30, Issue 2, 1996, Pages 79-93

  Abelson, James L ^a,b   Curtis, George C ^a   Cameron, Oliver G ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b Med Inn Bldg/0840 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPRAZOLAM; CORTICOTROPIN; HYDROCORTISONE;

ADULT; ARTICLE; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOTROPIN RELEASE; DISEASE SEVERITY; DRUG EFFECT; DRUG MECHANISM; HUMAN; HYDROCORTISONE RELEASE; HYPERCORTISOLISM; HYPOPHYSIS ADRENAL SYSTEM; ORAL DRUG ADMINISTRATION; PANIC; PRIORITY JOURNAL; SLEEP PATTERN;

EID: 0029887112     PISSN: 00223956     EISSN: None     Source Type: Journal    
DOI: 10.1016/0022-3956(95)00035-6     Document Type: Article

References (33)

1. Abelson, J. L., & Curtis, G. C. (1993). Discontinuation of alprazolam after successful treatment of panic disorder: A naturalistic follow-up study. Journal of Anxiety Disorders, 7, 107-117.
2. Abelson, J. L., & Curtis, G. C. in press. Hypothalamic-pituitary-adrenal axis activity in panic disorder: 24 hour secretion of adrenocorticotropin and cortisol. Archives of General Psychiatry.
3. Adam, K., Oswald, I., & Shapiro, C. (1984). Effects of loprazolam and of triazolam on sleep and overnight urinary cortisol. Psychopharmacology, 82, 389-394.
4. Ballenger, J., Burrows, G., DuPont, R. J., Lesser, I., Noyes, R. J., Pecknold, J., Rifkin, A., & Swinson, R. (1988). Alprazolam in panic disorder and agoraphobia: Results from a multicenter trial. I. Efficacy in short-term treatment. Archives of General Psychiatry, 45, 413-422.
5. Brambilla, F., Bellodi, L., Perna, G., Battaglia, M., Sciuto, G., Diaferia, G., Petraglia, F., Panerai, A., & Sacerdote, P. (1992). Psychoimmunoendocrine aspects of panic disorder. Neuropsychobiology, 26, 12-22.
6. Breier, A., Davis, O., Buchanan, R., Listwak, S. J., Holmes, C., Pickar, D., & Goldstein, D. S. (1992). Effects of alprazolam on pituitary-adrenal and catecholaminergic responses to metabolic stress in humans. Biological Psychiatry, 32, 880-890.
7. Calogero, A. E., Gallucci, W. T., Chrousos, G. P., & Gold, P. W. (1988). Interaction between GABAergic neurotransmission and rat hypothalamic corticotropin-releasing hormone secretion in vitro. Brain Research, 463, 28-36.
8. Cloninger, C. R. (1986). A unified biosocial theory of personality and its role in the development of anxiety states. Psychiatric Developments, 4, 167-226.
9. Coryell, W., & Noyes, R. (1988). HPA axis disturbance and treatment outcome in panic disorder. Biological Psychiatry, 24, 762-766.
10. Coryell, W., Noyes, R., & Reich, J. (1991), The prognostic significance of HPA-axis disturbance in panic disorder: A three-year follow-up. Biological Psychiatry, 29, 96-102.
11. Coryell, W., Noyes, R., & Schlechte, J. (1989). The significance of HPA axis disturbance in panic disorder. Biological Psychiatry, 25, 989-1002.
12. Curtis, G. C., Cameron, O. G., & Nesse, R. M. (1982). The dexamethasone suppression test in panic disorder and agoraphobia. American Journal of Psychiatry, 139, 1043-1046.
13. De Souza, E. B. (1990). Neuroendocrine effects of benzodiazepines. Journal of Psychiatric Research, 24(Suppl. 2), 111-119.
14. Gold, P. W., Pigott, T. A., Kling, M. A., Brandt, H. A., Kalogeras, K., Demitrack, M. A., & Geracioti, T. D. (1990). Hypothalamic-pituitary-adrenal axis in panic disorder. In: J. C. Ballenger (Ed.), Neurobiology of Panic disorder, pp. 313-320. New York: Wiley-Liss.
15. Gram, L. F., & Christensen, P. (1986). Benzodiazepine suppression of cortisol secretion: a measure of anxiolytic activity? Pharmacopsychiatry, 19, 19-22.
16. Holsboer, F., von Bardeleben, U., Buller, R., Heuser, I., & Steiger, A. (1987). Stimulation response to corti-cotropin-releasing hormone (CRH) in patients with depression, alcoholism and panic disorder. Hormone Metabolism Research, 16(Suppl.), 80-88.
17. Kalogeras, K. T., Calogero, A. E., Kuribayiashi, T., Khan, I., Gallucci, W. T., Kling, M. A., Chrousos, G. P., & Gold, P. W. (1990). In vitro and in vivo effects of the triazolobenzodiazepine alprazolam on hypothalamic-pituitary-adrenal function: Pharmacological and clinical implications. Journal of Clinical Endocrinology and Metabolism, 70, 1462-1471.
18. Kathol, R. G., Anton, R., Noyes, R., Lopez, A. L., & Reich, J. H. (1988). Relationship of urinary free cortisol levels in patients with panic disorder to symptoms of depression and agoraphobia. Psychiatry Research, 24, 211-221.
19. Kushler, R. H., & Brown. M. B. (1991). A model for the identification of hormone pulses. Statistics in Medicine, 10, 329-340.
20. Linkowski, P., Medlewicz, J., Kerkhofs, M., Leclercq, R., Golstein, J., Brasseur, M., Copinschi, G., & Van Cauter, E. (1987). 24 hour profiles of adrenocorticotropin, cortisol, and growth hormone in major depressive illness: effect of antidepressant treatment. Journal of Clinical Endocrinology and Metabolism, 65, 141-152.
21. Lopez, A. L., Kathol, R. G., & Noyes, R. (1990). Reduction in urinary free cortisol during benzodiazepine treatment of panic disorder. Psychoneuroendocrinology, 15, 23-28.
22. Pihoker, C., & Nemeroff, C. B. (1993). The role of corticotropin-releasing factor in the pathophysiology of anxiety disorders. In: R. Hoehn-Saric, & D. R. McLeod (Eds), Biology of anxiety disorders, pp. 103-119. Washington, D.C.: American Psychiatric Press.
23. Rapaport, M. H., Risch, S. C., Golshan, S., & Gillin, J. C. (1989). Neuroendocrine effects of ovine corticotropin-releasing hormone in panic disorder patients. Biological Psychiatry, 26, 344-348.
24. Roelfsema, F., Van Den Berg, G., Frölich, M., Veldhuis, J. D., Van Eijk, A., Buurman, M. M., & Etman, B. H. B. (1993). Sex-dependent alterations in cortisol response to endogenous adrenocorticotropin. Journal of Clinical Endocrinology and Metabolism, 77, 234-240.
25. Roy-Byrne, P. P., Cowley, D. S., Hommer, D., Ritchie, J., Greenblatt, D., & Nemeroff, C. (1991). Neuroendocrine effects of diazepam in panic and generalized anxiety disorders. Biological Psychiatry, 30, 73-80.
26. Roy-Byrne, P. P., Uhde, T. W., Post, R. M., Gallucci, W., Chrousos, G. P., & Gold, P. W. (1986). The corticotropin-releasing hormone stimulation test in patients with panic disorder. American Journal of Psychiatry, 143, 896-899.
27. Schittecatte, M., Charles, G., Nefve, C., Valentin, J. G., Machowski, R., & Wilmotte, J. (1992). Long-term downregulation of central adrenoreceptor function by desipramine treatment: a clonidine study in normal subjects. Biological Psychiatry, 31, 856-858.
28. Schreiber, W., Krieg, J. C., Bossert, S., Junker, M., Rauschhuber, R., Stalla, G. K., Müller, O. A., & Berger, M. (1988). Methodological aspects of HCRF-stimulated ACTH and cortisol secretion in healthy subjects. Psychoneuroendocrinology, 13, 487-495.
29. Schuckit, M. A., Hauger, R., & Klein, J. L. (1992). Adrenocorticotropin hormone response to diazepam in healthy young men. Biological Psychiatry, 31, 661-669.
30. Schürmeyer, T. H., Tomai, T. P., Steinbach, H., von zur Mühlen, A., & Gold, P. W. (1988). Pituitary and adrenal responses to insulin induced hypoglycemia and to CRH are modulated by anxiolytic pretreatment in man. In: R. D'Agata, & G. P. Chrousos (Eds), Recent advances in adrenal regulation and function, pp. 285-291. New York: Raven Press.
31. Spitzer, R. L., & Williams, J. B. W. (1986). Structured Clinical Interview for DSM-III-R-Upjohn Version-Revised: Biometrics Research Department, New York State Psychiatric Institute.
32. Teicher, M. H., & Barber, N. I. (1990). COSIFIT: An interactive program for simultaneous multioscillator cosinor analysis of time-series data. Computers and Biomedical Research, 23, 283-295.
33. Uhde, T., Joffe, R. T., Jimerson, D. C., & Post, R. M. (1988). Normal urinary free cortisol and plasma MHPG in panic disorder: clinical and theoretical implications. Biological Psychiatry, 23, 575-585.